Caricamento...
Anti-CD73 in cancer immunotherapy: awakening new opportunities
In recent years, cancer immunotherapy made significant advances due to a better understanding of the principles underlying tumor biology and immunology. In this context, CD73 is a key molecule, since via degradation of adenosine monophosphate into adenosine, endorses the generation of an immunosuppr...
Salvato in:
| Pubblicato in: | Trends Cancer |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800751/ https://ncbi.nlm.nih.gov/pubmed/27014745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.01.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|